✨ Free AI Report
Hikal Limited: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Hikal Limited
Company Research

Hikal Limited: Business Overview, Financials & Competitive Analysis

Hikal Ltd. is a leading Indian company providing pharmaceutical and crop protection solutions, including Active Pharmaceutical Ingredients (APIs), intermediates, and specialty chemicals. The company is the preferred p...

Analyst-debate audio for Hikal Limited

AskCyborg analysts argue the bull and bear cases for Hikal Limited across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
4/ 10Mixed

Cyborg Score thesis

Challenged fine chemicals provider with regulatory headwinds; turnaround hinges on CDMO expansion and operational recovery from...

Read the full analyst-debate transcript →
Industry Pharmaceuticals & Biotechnology - Fine Chemicals / Active Pharmaceutical Ingredients
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Hikal Limited Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Hikal Limited Overview

Pro stress-test →

Hikal Ltd. is a leading Indian company providing pharmaceutical and crop protection solutions, including Active Pharmaceutical Ingredients (APIs), intermediates, and specialty chemicals. The company is the preferred partner for pharmaceuticals and crop protection companies, with a vision to be the leading global fine chemical provider to the Pharmaceutical, Crop Protection, and Specialty Chemical industries.

Strategic Profile

Pro stress-test →

Hikal is engaged in the business of pharmaceuticals, crop protection, and specialty chemicals. Strategic shifts towards enhancing its CDMO services and diversifying into personal care and specialty chemicals are expected to drive future growth. However, the company is currently facing headwinds with recent regulatory challenges and declining profitability.

Competitive Landscape

Pro stress-test →

In the last 1 year, Torrent Pharmaceuticals Ltd has given 23.1% return, outperforming Hikal stock by 64.8%. Hikal competes against larger integrated pharma and specialty chemicals companies in India and globally. The company's growth underperformance reflects competitive pressures and regulatory challenges in the pharmaceutical manufacturing space.

Industry Context

Hikal Limited operates in Pharmaceuticals & Biotechnology - Fine Chemicals / Active Pharmaceutical Ingredients.

Key facts

Founded: 1988 · Headquarters: Mumbai, India · Revenue: ₹316.2 Cr (Q2 FY26) · Market cap: ₹2,845.5 Cr (Nov 2025)

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Hikal Limited.

  • Consolidated revenue of Rs. 380 crores for Q1 FY26, reflecting a decline from the previous year primarily due to deferred shipments in its Pharmaceutical division.
  • Share transfer for amalgamation executed; scheme sanctioned Nov 18, 2025, effective Dec 1, 2025, with former promoter-group shares moved to Castilia Life Sciences.
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Castilia Life Sciences converted to LLP with 24.52% HIKAL shareholding vested
  • February 2025US FDA inspection at Jigani facility concluded with six observations requiring remediation
  • +1 moreTrack every material event for Hikal Limited as it happens. Explore monitoring →
Get alerted when Hikal Limited has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Torrent PharmaceuticalsIntegrated pharmaceutical company with stronger recent market performance→Sinochem CorporationStrategic investor and chemical manufacturing competitor→NovartisFormer agrochemical manufacturing facility provider→

Compare Hikal Limited with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Hikal Limited operates in Pharmaceuticals & Biotechnology - Fine Chemicals / Active Pharmaceutical Ingredients. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals & Biotechnology - Fine Chemicals / Active Pharmaceutical Ingredients research →
NEW · MCP server

Ask your AI assistant about Hikal Limited

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Hikal Limited and its top competitor on Cyborg Score”
“What did Hikal Limited do this quarter?”
“Is Hikal Limited a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Hikal Limited do?+
Hikal Ltd. is a leading Indian company providing pharmaceutical and crop protection solutions, including Active Pharmaceutical Ingredients (APIs), intermediates, and specialty chemicals. The company is the preferred p...
What is Hikal Limited's Cyborg Score?+
Hikal Limited has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Hikal Limited's main competitors?+
Named competitors include Torrent Pharmaceuticals, Sinochem Corporation, Novartis. The full competitive landscape is in the AskCyborg report.
How can I get the full Hikal Limited research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Hikal Limited research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Hikal Limited over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Pharmaceuticals & Biotechnology - Fine Chemicals research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7Novartis AG